Nivolumab Therapy for Treatment-Related Vitiligo in a Patient With Relapsed Metastatic Melanoma.
JAMA Dermatol, 2017/09/01;153(9):942-944.
Nakamura Y[1], Teramoto Y[1], Asami Y[1], Matsuya T[1], Adachi JI[2], Nishikawa R[2], Yamamoto A[1]
Affiliations
PMID: 28678991DOI: 10.1001/jamadermatol.2017.1679
Impact factor: 11.816
MeSH terms
Adult; Antineoplastic Agents, Immunological; Biopsy; Humans; Male; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nivolumab; Skin; Vitiligo
More resources
EndNote: Download